"I think the Government has a part to play in reclassifying these things that could be harmful but can be sold
Many commercial health plans and employer-sponsored benefit programs either exclude anti-obesity medications from formularies entirely or place them on higher cost-sharing tiers, resulting in limited or no insurance coverage for patients, even when clinically appropriate
Sourced 100% from Norwegian salmon via Seagarden
Does Semaglutide affect kidney or liver function
GLP-1 RAs promote weight loss, enhancing satiety, reducing caloric intake, and delaying gastric emptying, which together reduce both the mechanical burden in intertriginous areas and systemic inflammation
Shah VN, Peters AL, Umpierrez GE, Sherr JL, Akturk HK, Aleppo G, Bally L, Cengiz E, Cinar A, Dungan K, Fabris C, Jacobs PG, Lal RA, Mader JK, Masharani U, Prahalad P, Schmidt S, Zijlstra E, Ho CN, Ayers AT et al (2025) Consensus report on glucagon-like peptide-1 receptor agonists as adjunctive treatment for individuals with type 1 diabetes using an automated insulin delivery system
